The elevated reporting odds ratios (RORs) observed for “elevated blood gastrin,” “gastric mucosal hypertrophy,” and “gastric polyp bleeding” in this study provide pharmacovigilance support for this biological mechanism. The gene discussed is GAST; the disease is gastric mucosal hypertrophy.